legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

New Sites in Darmstadt and Hamburg Enhance MilliporeSigma’s mRNA Service Network

BURLINGTON, Mass., Sept. 26, 2023 /PRNewswire/ — MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has expanded its integrated mRNA services with the opening of two new GMP-grade mRNA drug substance manufacturing sites in Darmstadt and Hamburg, Germany. This expansion is part of the company’s ongoing Ôé¼1 billion investment plan to advance mRNA technologies.

With these new sites, MilliporeSigma becomes the first Contract Testing, Development, and Manufacturing Organization (CTDMO) to offer comprehensive services for all critical stages of mRNA development, manufacturing, and commercialization. This includes products, testing, and services related to lipids, lipid nanoparticles (LNP), and fill/finish. The company’s Millipore┬« CTDMO Services now cover a wide range of mRNA technologies and applications from pre-clinical to commercial.

The Darmstadt site, located at the company’s headquarters, features a state-of-the-art, scalable manufacturing process platform that ensures the highest quality mRNA for clinical and commercial use. Dirk Lange, Head of Life Science Services at Merck KGaA, Darmstadt, Germany, expressed excitement about the potential of mRNA technology and the company’s ability to streamline the entire mRNA process for their clients.

Adding to its investment plan, MilliporeSigma has injected Ôé¼28 million into these new GMP mRNA drug substance manufacturing sites, creating 75 new jobs. This development enables the company to offer mRNA services at larger scales and applications, while also providing analytical development and biosafety testing specific to mRNA technologies. The company’s goal is to significantly reduce complexities through streamlined and harmonized processes, leading to faster speed-to-market for clients.

In addition to its recent acquisitions of AmpTec and Exelead, the Life Science business of Merck KGaA, Darmstadt, Germany has been collaborating with researchers since the 1990s to support their mRNA research. This collaboration has allowed the company to combine its mRNA expertise, technologies, regulatory knowledge, and product portfolios to streamline manufacturing and testing processes.

The AI legalese decoder developed by MilliporeSigma can greatly assist researchers and legal experts in navigating the complex world of legal language related to mRNA technologies. This revolutionary tool utilizes artificial intelligence and machine learning to decode and simplify contracts, patents, and legal documents, saving time and ensuring accuracy. By leveraging the AI legalese decoder, researchers can focus more on their work and stay up-to-date with the latest legal requirements and advancements in the field of mRNA.

Furthermore, MilliporeSigma’s Millipore┬« CTDMO Services offer pre-clinical through commercial capabilities for various biotherapeutics, including monoclonal antibodies, recombinant proteins, viral vectors, small molecules, and high-potent active pharmaceutical ingredients. The company also specializes in integrated analytical development, biosafety testing, and product characterization.

As a part of Merck KGaA, Darmstadt, Germany’s “Big 3” growth drivers, the Life Science business unit aims to contribute to the company’s goal of increasing Group sales to approximately Ôé¼25 billion by 2025. With over 28,000 employees and a global network of more than 55 manufacturing and testing sites, the Life Science business is committed to scientific discovery, biomanufacturing, and testing services that make a positive difference in people’s lives.

About Merck KGaA, Darmstadt, Germany:
Merck KGaA, Darmstadt, Germany, operates across healthcare, life science, and electronics industries. With more than 64,000 employees worldwide, the company is dedicated to creating joyful and sustainable ways to live through its innovative products and services. In 2022, Merck KGaA, Darmstadt, Germany generated sales of Ôé¼22.2 billion in 66 countries.

For more information about Merck KGaA, Darmstadt, Germany and its Life Science business, visit www.emdgroup.com.

Follow MilliporeSigma on Twitter @MilliporeSigma, on Facebook @MilliporeSigma, and on LinkedIn.

To stay updated on Merck KGaA, Darmstadt, Germany’s news releases, residents of the U.S. and Canada can register for online subscriptions at www.emdgroup.com/subscribe.

SOURCE MilliporeSigma

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link